ECT, Anesthesia
Conditions
Keywords
electroconvulsive therapy, seizures, sevoflurane
Brief summary
The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles
Detailed description
Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean arterial pressure (MAP) values, and recovery times were recorded.
Interventions
DRUGsevorane
Sevorane 4% Sevorane 7%
Sponsors
Inonu University
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Study included 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who were scheduled for ECT sessions under general anesthesia
Exclusion criteria
* Pregnancy * Cerebrovascular disease * Epilepsy * Unstable cardiovascular disease * Chronic obstructive pulmonary disease; and * Renal or hepatic failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure | taken prior to the seizure |
Secondary
| Measure | Time frame |
|---|---|
| sevoflurane used in electroconvulsive therapy (ECT) on hemodynamic response. | taken prior to the seizure |
Countries
Turkey (Türkiye)
Outcome results
None listed